Health Analytics Connect

Recording: Transforming Healthcare Analytics: Strategies & Tools for Actionable Insights and Improved Outcomes
Discover how you can transform your healthcare data into invaluable, actionable assets for decision-making and strategic planning with Analytics Recipes that can specifically help you address your members’ pressing healthcare issues like GLP-1 therapies, childhood obesity, and Peripheral Artery Disease (PAD), direct to consumer automated streamlined reporting, and dedicated training programs structured to bolster the capabilities of your analytics teams.

Presentation: Transforming Healthcare Analytics: Strategies & Tools for Actionable Insights and Improved Outcomes
Discover how you can transform your healthcare data into invaluable, actionable assets for decision-making and strategic planning with Analytics Recipes that can specifically help you address your membersâ?? pressing healthcare issues like GLP-1 therapies, childhood obesity, and Peripheral Artery Disease (PAD), direct to consumer automated streamlined reporting, and dedicated training programs structured to bolster the capabilities of your analytics teams.

Health Alliance Spotlight Webinar Presentation Deck
Presentation Deck for Spotlight Webinar

Analytic Recipes Overview
At Health Analytics Connect, our commitment is to the dynamic application of data analytics in empowering healthcare stakeholders. We appreciate the complexity of the healthcare field and tailor our analysis to suit the unique needs of each stakeholder. Our methodology extends beyond traditional data reporting; we delve into strategic insight generation, enabling stakeholders to make informed and visionary decisions. With a keen focus on anticipating future market trends, we are adept at equipping our clients with the foresight essential for navigating the evolving healthcare sector.

Analytic Recipe 01 Analysis of Rising Pharmacy Costs and Trends in GLP-1/SGLT-2 Drug Utilization
Health Analytics Connect: Your Partner in GLP-1 / SGLT-2 Drug Cost Analyses Health Analytics Connect serves as an indispensable resource for employers and insurers tackling the complex challenges associated with the costs of GLP-1 and SGLT-2 drugs. Our advanced data analytics platform offers deep insights into the usage trends, efficacy, and financial impacts of these medications, vital for navigating the evolving healthcare landscape. Equipped with predictive modeling and comprehensive trend analysis capabilities, we empower you with the tools necessary for informed decision-making, strategic policy development, and effective cost management.

Analytic Recipe 2 - Childhood Obesity in the United States
Health Analytics Connect: Data-Driven Strategies in Combatting Childhood Obesity Health Analytics Connect emerges as a vital partner for employers and insurers in navigating these complexities. The rising trend of childhood obesity in the United States, affecting over 20% of children aged 2 to 19, is a significant public health concern. This complex issue varies across different demographics, requiring multifaceted and tailored strategies. Modern approaches have shifted from traditional nutrition and behavior-focused methods to holistic strategies that include regulating food marketing and family-centric programs. Data analytics plays a crucial role in this fight against childhood obesity. It helps in identifying at-risk populations through the analysis of health records and socioeconomic data, leading to more targeted and effective interventions. Additionally, data analytics is vital in evaluating the impact and success of these strategies, ensuring they are adaptable and efficient.

Analytic Recipe 3 - Unmasking the Vape Cloud
In the evolving terrain of employer-sponsored health plans, the ascent of vaping has become a focal point due to its intricate financial and health repercussions. Vaping, increasingly implicated in a host of serious health conditions such as lung injuries, cardiovascular disorders, and respiratory complications, poses significant risks. This troubling trend is mirrored in the escalating healthcare costs burdening employers, evident in the rising tide of medical claims and treatment expenditures for employees suffering from vaping-related ailments. Data from the 2015-2018 National Health Interview Surveys starkly illustrates this scenario, revealing an alarming $15.1 billion in healthcare expenses linked to e-cigarette use, encompassing $1.3 billion for exclusive e-cigarette users and a more significant $13.8 billion for those combining e-cigarettes with other tobacco products.

Analytic Recipe 4 - Harnessing Data Analytics to Combat PAD
PAD's impact on patients and healthcare systems is profound, with certain observations highlighting the economic and health-related challenges it presents: Roughly 1% of the commercial population is diagnosed with PAD, with about 2.5% of these patients undergoing leg amputation annually. A significant majority, approximately 85% of PAD patients, suffer from two or more chronic conditions, with half of them dealing with four or more comorbidities. The cost of managing PAD patients with additional chronic conditions escalates rapidly, being approximately five times higher than for those with PAD alone. PAD patients incur overall claimant costs that are double those of the average member, which quadruples in cases involving amputation.